Juozas Nainys, Atrandi Biosciences CEO
February 18, 2025 07:00 AM EST
Financing
Startups

Ex­clu­sive: Lux leads $25M Se­ries A in a Lithuan­ian start­up plot­ting US ex­pan­sion

Andrew Dunn

Senior Biopharma Correspondent

A biotech based in Vil­nius, Lithua­nia has won the back­ing of Lux Cap­i­tal as the start­up plots a US ex­pan­sion in 2025.

Lux led a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Bridge­Bio’s heart dis­ease drug At­tru­by sails past pre­scrip­tion es­ti­mates

Can amylin drugs take over from GLP-1s in obe­si­ty? Part­ner­less Zealand thinks so

In sin­gle case, spinal mus­cu­lar at­ro­phy pill giv­en be­fore birth spared ba­by of ge­net­ic dis­ease symp­toms

How Keymed steered the Chi­na-to-US New­Co mod­el in biotech

Will CRISPR mat­ter?

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times